ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L04AA32 | G | Apremilast - 30mg | 11379 | 153921/1 | APRIVA | 30mg | 60 | Tablet, film coated | Oral | Droguerie Mercury S.A.L. | Hikma Pharmaceuticals | Jordan | 41,455,526 L.L | 10.71 | E1 | Hikma Pharmaceuticals | Jordan | 2/5/2024 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L04AA32 | B | Apremilast - 30mg | 10540 | 99320/1 | OTEZLA | 30mg | 56 | Tablet, film coated | Oral | Mersaco | Patheon Inc | Canada | 49,829,454 L.L | 10.71 | E1 | Amgen Europe BV | The Netherlands | 2/5/2024 | 0 |